Given the high proportion of triple-negative breast cancer in BLBC and the common feature of BRCA1-defective breast cancer and BLBC, perhaps for the treatment modalities of CNC, we can attempt to use targeted therapy for BRCA1. Here, BRCA1 is linked to Carney complex.